Pharmaceutical Stocks To Watch Now – January 30th

Thermo Fisher Scientific, Eli Lilly and Company, and Johnson & Johnson are the three Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. Pharmaceutical stocks refer to shares of companies that specialize in the research, development, manufacturing, and marketing of pharmaceutical products such as prescription drugs and vaccines. Investors may choose to invest in these stocks as part of their portfolio to potentially benefit from the growth and profitability of the pharmaceutical industry. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Thermo Fisher Scientific (TMO)

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.

Shares of NYSE:TMO traded up $38.72 during midday trading on Thursday, hitting $606.95. 1,953,886 shares of the stock were exchanged, compared to its average volume of 2,035,430. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.26 and a current ratio of 1.63. Thermo Fisher Scientific has a 52-week low of $493.30 and a 52-week high of $627.88. The business’s fifty day simple moving average is $537.83 and its two-hundred day simple moving average is $570.33. The company has a market capitalization of $232.16 billion, a PE ratio of 38.11, a P/E/G ratio of 3.82 and a beta of 0.76.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Shares of NYSE LLY traded up $13.77 during trading hours on Thursday, hitting $817.85. 1,177,500 shares of the stock were exchanged, compared to its average volume of 3,841,148. The firm has a market capitalization of $776.40 billion, a P/E ratio of 88.40, a P/E/G ratio of 1.59 and a beta of 0.41. Eli Lilly and Company has a one year low of $637.00 and a one year high of $972.53. The company has a debt-to-equity ratio of 2.03, a current ratio of 1.27 and a quick ratio of 0.97. The company’s 50 day moving average is $780.80 and its 200 day moving average is $845.98.

Johnson & Johnson (JNJ)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.

Shares of NYSE:JNJ traded up $2.74 during midday trading on Thursday, hitting $153.89. The company’s stock had a trading volume of 3,563,013 shares, compared to its average volume of 9,399,796. The stock has a market capitalization of $370.51 billion, a price-to-earnings ratio of 23.14, a PEG ratio of 2.45 and a beta of 0.51. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.79 and a current ratio of 1.03. The stock’s 50 day simple moving average is $147.73 and its 200 day simple moving average is $156.10. Johnson & Johnson has a fifty-two week low of $140.68 and a fifty-two week high of $168.85.